SRL172 killed suspension of Mycobacterium vaccae: Phase I/II data; Phase II

Preliminary results of a placebo-controlled Phase I/II trial in 24 patients with perennial asthma showed that a single dose of SRL174 conferred superior tolerance to dust mite allergen challenge than ...